We are live on ! Find out more
Glazer Capital

Glazer Capital Portfolio holdings

AUM $4.67B Turnover 37.63%
1-Year Est. Return 66.86%
 

Glazer Capital runs event-driven strategies that aim to make money when an announced merger, acquisition or tender offer closes successfully. Its four main strategies are merger arbitrage, event-driven fixed income, convertible arbitrage and arbitrage on SPACs, and it invests across companies' capital structures, in both stocks and debt. Founder and chief executive Paul Glazer spent ten years on the sell side at Houlihan Lokey, Jefferies, Bear Stearns and Oscar Gruss, where he focused on merger arbitrage. He and Mark Ort, head of strategic initiatives, are the firm's principal owners. In 2010 it began offering leveraged versions of its strategies at investors' request, and in 2024 it opened an office in the UK.

This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+66.86%
3 Year Est. Return
+328.24%
5 Year Est. Return
+621.16%
10 Year Est. Return
+3,600.33%
AUM
$4.67B
AUM Growth
+$601M
Cap. Flow
+$137M
Cap. Flow %
2.94%
Top 10 Hldgs %
31.98%
Holding
744
New
175
Increased
146
Reduced
149
Closed
105
Avg Time Held Equity + Options
0.4 years
Top 10 Avg Time Held Equity + Options
0 years
Top 20 Avg Time Held Equity + Options
0 years
Avg Time Held Equity only
0.4 years
Top 10 Avg Time Held Equity only
0 years
Top 20 Avg Time Held Equity only
0 years

Top Sells

Rank Stock Value
1
JHG icon
Janus Henderson
JHG
+$324M
2
NUVL icon
Nuvalent
NUVL
+$219M
3
APGE icon
Apogee Therapeutics
APGE
+$218M
4
BLD icon
TopBuild
BLD
+$210M
5
SEM icon
Select Medical
SEM
+$177M

Sector Composition

Rank Sector Weight
1 Financials 52.2%
2 Healthcare 13.63%
3 Communication Services 8.81%
4 Miscellaneous 8.07%
5 Utilities 4.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AXINU icon
601
Axiom Intelligence Acquisition Corp 1 Units
AXINU
$189M
$1K ﹤0.01%
91
– –
2026 Q1
2 quarters
PACHU icon
602
Pioneer Acquisition I Corp Units
PACHU
$1K ﹤0.01%
+101
New +$1.05K
2026 Q3
0 quarters
FIGXU icon
603
FIGX Capital Acquisition Corp Units
FIGXU
$142M
$1K ﹤0.01%
+101
New +$1.05K
2026 Q3
0 quarters
BCSS.U icon
604
Bain Capital GSS Investment Units
BCSS.U
$1K ﹤0.01%
131
– –
2025 Q3
4 quarters
HCACU icon
605
Hall Chadwick Acquisition Corp Unit
HCACU
$195M
$1K ﹤0.01%
72
– –
2026 Q2
1 quarter
DSACU icon
606
Daedalus Special Acquisition Corp Unit
DSACU
$1K ﹤0.01%
89
– –
2025 Q4
3 quarters
IRHOU icon
607
Iron Horse Acquisitions II Corp Units
IRHOU
$1K ﹤0.01%
144
– –
2026 Q2
1 quarter
LPCVU icon
608
Launchpad Cadenza Acquisition Corp I Unit
LPCVU
$204M
$1K ﹤0.01%
+55
New +$555
2026 Q3
0 quarters
XSLLU icon
609
Xsolla SPAC 1 Units
XSLLU
$1K ﹤0.01%
100
– –
2026 Q2
1 quarter
CLBR.U icon
610
Colombier Acquisition Corp III Units
CLBR.U
$1K ﹤0.01%
66
– –
2026 Q1
2 quarters
RFAMU icon
611
RF Acquisition Corp III Units
RFAMU
$1K ﹤0.01%
133
– –
2026 Q1
2 quarters
IPFXU icon
612
Inflection Point Acquisition Corp VI Units
IPFXU
$227M
$1K ﹤0.01%
+100
New +$1.06K
2026 Q3
0 quarters
ACGCU icon
613
ACP Holdings Acquisition Corp Units
ACGCU
$1K ﹤0.01%
+50
New +$522
2026 Q3
0 quarters
ACLS icon
614
Axcelis
ACLS
$2.79B
– –
-11,656
Closed -$2.21M –
ALOT icon
615
DELISTED
AstroNova
ALOT
– –
-449,920
Closed -$12.8M –
ANSC
616
DELISTED
Agriculture & Natural Solutions Acquisition Corp
ANSC
– –
-999,384
Closed -$11.4M –
APGE icon
617
DELISTED
Apogee Therapeutics
APGE
– –
-1,641,042
Closed -$218M –
AVNS icon
618
DELISTED
Avanos Medical
AVNS
– –
-259,736
Closed -$6.46M –
BLD icon
619
DELISTED
TopBuild
BLD
– –
-492,249
Closed -$210M –
BLD icon
620
PUT
DELISTED
TopBuild
BLD
– –
-192
Closed -$1.76M –
BSX icon
621
Boston Scientific
BSX
$60.8B
– –
-17,999
Closed -$768K –
CCO icon
622
DELISTED
Clear Channel Outdoor Holdings
CCO
– –
-12,298,891
Closed -$29.8M –
CCRN icon
623
DELISTED
Cross Country Healthcare
CCRN
– –
-1,111,727
Closed -$14.7M –
COTY icon
624
Coty
COTY
$3.48B
– –
-10,168
Closed -$22K –
CPRX icon
625
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-3,602,865
Closed -$113M –

Similar funds

Glazer Capital's Q3 2026 Portfolio in Review

As of Q3 2026, Glazer Capital held 744 positions worth $4.67B, up 15% from $4.07B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Glazer Capital's Q3 2026 filing shows 175 new, 146 increased, 149 reduced and 105 closed positions. Its largest new stake was Baldwin Insurance Group: 7,230,877 shares worth $230M. The largest sale was Janus Henderson, an estimated $324M.

By sector, the portfolio is most concentrated in Financials at 52% of assets, up from 48% a quarter earlier, followed by Healthcare and Communication Services.

  • Glazer Capital's largest Q3 2026 buy was Baldwin Insurance Group: 7,230,877 shares worth $230M.
  • Glazer Capital added most to Warner Bros in Q3 2026, an estimated $227M increase.
  • Glazer Capital's biggest Q3 2026 reduction was Caesars Entertainment, cutting an estimated $68.9M.
  • Glazer Capital fully exited Janus Henderson in Q3 2026, selling an estimated $324M.
  • Glazer Capital's ten largest holdings make up 32% of its $4.67B portfolio in Q3 2026.
  • Glazer Capital opened 175 new positions and closed 105 in Q3 2026.
  • Glazer Capital's portfolio value rose 15% quarter-over-quarter to $4.67B.

Based on Glazer Capital's 13F filing for Q3 2026, filed 17 Nov 2026.